Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Based on Phase 3 trial completion timelines, analysts project an NDA submission in late 2026 or early 2027, with FDA review taking approximately 12 months
You can't build upon or trust data that comes from a compromised foundation
Each company is profiled using a standardized format that includes: Company Profiles Novo Nordisk Business Overview Company Snapshot Products Overview Company Market Share Analysis Company Coverage Portfolio Financial Analysis Recent Developments Merger and Acquisitions SWOT Analysis Eli Lilly and Company Sanofi AstraZeneca Pfizer Inc
albicans followed by characterisation of growth under hyphae-inducing conditions
US$ 22.01
US$ 20.39
US$ 28.48
US$ 28.03
US$ 21.13
US$ 21.78
US$ 22.88
US$ 22.06
US$ 24.92
US$ 26.53
US$ 20.88
US$ 21.86
US$ 26.22
